Please login to the form below

Not currently logged in
Email:
Password:

complementary therapies

This page shows the latest complementary therapies news and features for those working in and with pharma, biotech and healthcare.

Takeda agrees $5.2bn deal to buy Ariad

Takeda agrees $5.2bn deal to buy Ariad

Opportunities to acquire such high-quality, complementary targeted therapies do not come often, and we are very excited about the potential for this transaction to benefit patients, our shareholders, and other

Latest news

  • UCB launches arthritis exercise programme in the UK

    However, the move comes just as Arthritis Research UK publish a report that criticises many complementary therapies for arthritis as lacking scientific evidence of efficacy. ... Rheumatoid arthritis was singled out in the report as being an area where

  • Finding patterns in past market research

    Yet, with all these advances in medical science, there has also been an enormous shift over the last 10 years towards, or perhaps it should be back to, complementary therapies. ... Yet, in other case studies, parents are often more willing to try

  • R&D news in brief

    Last month, a report written by economist Christopher Smallwood and commissioned by the Prince of Wales said that complementary therapies, including herbal medicines, should be used more frequently by the NHS.

  • Doctors attack NHS support of complementary medicine

    It criticised two initiatives - a government-funded guide on homeopathy for patients, and the Smallwood Report, which was commissioned by Prince Charles, and advocates greater access to complementary therapies. ... She said: ìPatients rightly expect to

  • New laws for alternative medicines in UK

    The UK government will regulate aromatherapy, homoeopathy and other complementary therapies in a scheme due later in 2008. ... The NHS spends GBP 50m a year on complementary therapies, which will be covered by the new council.

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Media

Four Health Media creates world class integrated media solutions with global reach, deep insight, innovative methods and a highly personal...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics